Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Myosin heavy chain 14 (MYH14) encodes a conventional non-muscle myosin that is part of the myosin superfamily of actin-dependent motor proteins. These proteins are responsible for generating force and movement in cells by converting chemical energy from ATP hydrolysis into mechanical work. MYH14 participates in cellular processes such as cytokinesis, maintenance of cell shape, cell motility, and specialized activities like secretion. Mutations in MYH14 are causative for certain forms of autosomal dominant hearing impairment (DFNA4A) and other disorders such as peripheral neuropathy and myopathy. Multiple isoforms exist due to transcript variation[1][2][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Myosin heavy chain 14 (MYH14).